20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler

RxNorm concept 759471, clinical drug (scd). Prescribable name: zanamivir 5 MG/INHAL Dry Powder Inhaler, 20 Blisters.

RxCUI: 759471
Term type: Clinical drug (SCD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/759471 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

zanamivir 69722

Other names

zanamivir 5 MG/ACTUAT Dry Powder Inhaler, 20 ACTUAT

Related concepts

zanamivir 5 MG/ACTUAT (SCDC, consists of)
Dry Powder Inhaler (DF, has dose form)
20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler [Relenza] (SBD, has tradename)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 759471 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/759471 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 759471. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.